Stay updated on Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial
Sign up to get notified when there's something new on the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page.

Latest updates to the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe page footer revision label has been updated from **v3.5.2** to **v3.5.3**. This appears to be a general site release/version update rather than a change to the study details.SummaryDifference0.1%

- Check21 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedThe page shows an added Revision: v3.5.0 and a removed Revision: v3.4.3. This appears to be an administrative versioning update rather than a modification to the study data or content.SummaryDifference0.1%

- Check57 days agoChange DetectedThe site revision was updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check78 days agoChange DetectedPrimary outcome maintenance phase wording updated to 'Baseline through Week 48' from 'post-randomization through Week 48'.SummaryDifference0.3%

- Check85 days agoChange DetectedThe change is a minor revision update from v3.4.1 to v3.4.2; no substantive content changes are apparent. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page.